SCHEMBL20090166

SCHEMBL20090166

S=P(c1ccccc1)(c1ccccc1)c1ccc2c(ccc3cc(-c4ccc5c(c4)c4c6ccccc6ccc4c4nc6ccc(-c7cccc8ccccc78)cc6n54)ccc32)c1

nearest known ligand 0.32

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.32
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
CASP1 P29466 1/20 0.31
CYP2C19 P33261 1/20 0.31
CASP7 P55210 1/20 0.31
CAMKK1 Q8N5S9 1/20 0.31
CAMKK2 Q96RR4 1/20 0.31
FLT3 P36888 1/20 0.30
HPGD P15428 3/20 0.30
ALDH1A1 P00352 2/20 0.30
KDM4E B2RXH2 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20090180 0.96 KDM4E (0.33) AHRMAPTHPGDALDH1A1KDM4E
SCHEMBL20090162 0.95 AHR (0.34) AHRKMT2AMEN1CYP1A2CYP2D6
SCHEMBL20096487 0.94 KDM4E (0.32) AHRMAPTHPGDALDH1A1KDM4E
SCHEMBL20090245 0.93 KDM4E (0.31) AHRMAPTFLT3HPGDALDH1A1
SCHEMBL20090155 0.90 AHR (0.34) AHRKMT2AMEN1CYP1A2CYP2D6
SCHEMBL19960261 0.89 AHR (0.32) AHRKMT2AMEN1CYP1A2CYP2D6
SCHEMBL19960339 0.89 ALDH1A1 (0.34) AHRKMT2AMEN1CYP1A2CYP2D6
SCHEMBL20090174 0.89 AHR (0.33) AHRKMT2AMEN1CYP1A2CYP2D6
SCHEMBL20090241 0.89 CYP11B1 (0.40) CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL19960271 0.88 AHR (0.35) AHRKMT2AMEN1CYP1A2CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-07-16 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114923-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 AHR 58/4885KMT2A 443/4885MEN1 885/4885
US-10355225-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 AHR 58/4885KMT2A 443/4885MEN1 885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.